ZNF618 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.690400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.866600E-01
Normal-vs-Stage2
4.415900E-03
Normal-vs-Stage3
1.602560E-01
Normal-vs-Stage4
3.638600E-01
Stage1-vs-Stage2
4.362000E-03
Stage1-vs-Stage3
2.948000E-02
Stage1-vs-Stage4
4.432800E-01
Stage2-vs-Stage3
3.864600E-03
Stage2-vs-Stage4
3.890000E-01
Stage3-vs-Stage4
2.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.428300E-02
Normal-vs-AfricanAmerican
1.151760E-01
Normal-vs-Asian
4.048100E-02
Caucasian-vs-AfricanAmerican
7.223200E-01
Caucasian-vs-Asian
6.432400E-01
AfricanAmerican-vs-Asian
9.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.708400E-02
Normal-vs-Female
9.587800E-02
Male-vs-Female
8.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.208400E-01
Normal-vs-Age(41-60Yrs)
1.185150E-01
Normal-vs-Age(61-80Yrs)
5.718200E-02
Normal-vs-Age(81-100Yrs)
6.601900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.014200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.344000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.307000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.927000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.611200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.346600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.277100E-03
Normal-vs-Daily Drinker
3.203800E-02
Normal-vs-Weekly Drinker
2.818800E-01
Normal-vs-Occasional Drinker
3.590400E-01
Normal-vs-Social Drinker
3.869400E-01
Non Drinker-vs-Daily Drinker
9.266000E-01
Non Drinker-vs-Weekly Drinker
3.932200E-01
Non Drinker-vs-Occasional Drinker
2.865400E-01
Non Drinker-vs-Social Drinker
1.111970E-01
Daily Drinker-vs-Weekly Drinker
3.820800E-01
Daily Drinker-vs-Occasional Drinker
2.897000E-01
Daily Drinker-vs-Social Drinker
9.396300E-02
Weekly Drinker-vs-Occasional Drinker
5.419400E-01
Weekly Drinker-vs-Social Drinker
2.603400E-01
Occasional Drinker-vs-Social Drinker
7.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.374600E-01
Normal-vs-Grade 2
2.840600E-01
Normal-vs-Grade 3
2.230800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.238000E-02
Grade 1-vs-Grade 3
1.015200E-01
Grade 1-vs-Grade 4
3.374600E-01
Grade 2-vs-Grade 3
6.943900E-02
Grade 2-vs-Grade 4
2.840600E-01
Grade 3-vs-Grade 4
2.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.218800E-03
Normal-vs-NonDiabetic
1.070820E-01
Diabetic-vs-NonDiabetic
1.131790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.045800E-01
Normal-vs-NoPancreatitis
7.865900E-02
Pancreatitis-vs-NoPancreatitis
2.978500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.003400E-01
Normal-vs-N1
5.738600E-03
N0-vs-N1
2.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.867600E-01
Normal-vs-TP53-NonMutant
5.244400E-01
TP53-Mutant-vs-TP53-NonMutant
4.757600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
